Caballero, Jhesrille P.
HRN: 22-35-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/14/2023
10/20/2023
IV
140mg
OD
PCAP-severe
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes